Ticker: IMUX

Company Overview Immunic, Inc. (NASDAQ: IMUX) is a biotechnology firm focusing on selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. They are headquartered in New York City and have significant operations in Germany. Recent Developments 1. The Phas...